Keratoconus and corneal cross-linking: detection, progression and management

Keratoconus used to be a diagnosis of spectacle intolerance: you found it when glasses stopped working, fitted a rigid lens, and waited to see whether the patient would eventually need a graft. Cross-linking changed the question from how do we correct this to can we stop it — and in doing so made early detection matter far more than it used to.

Why detection moved earlier

If progression can be halted, the clinical value of finding the disease before significant corneal distortion is obvious. That has pushed diagnosis from slit-lamp signs — which appear late — towards tomography, and towards screening the fellow eye and first-degree relatives of index cases.

It has also made refractive surgery screening a keratoconus problem: identifying a subclinical cone before laser ablation is one of the highest-consequence uses of corneal imaging in practice.

What imaging actually tells you

Anterior curvature alone is not enough

Placido-based topography maps the front surface. Early disease frequently shows on the posterior surface and in the pachymetric distribution first, which is why tomography — giving both surfaces and a full thickness map — has become the reference.

Progression is a pattern, not a single number

A change in one index on one visit is noise as often as it is signal. Established practice looks for consistent change across steepening, posterior elevation and thinning, and compares like with like: same device, ideally same operator.

Age weights the evidence

Keratoconus in an adolescent behaves more aggressively than the same tomographic picture at forty. Age belongs in the decision, not just the numbers.

Cross-linking: what it does and does not do

Corneal cross-linking uses riboflavin and ultraviolet-A light to increase the biomechanical stiffness of the stroma. Its purpose is to halt progression. Some flattening is frequently observed, but treating it as a refractive procedure sets an expectation the treatment was not designed to meet — and patient disappointment after a technically successful cross-link almost always traces back to that conversation.

The main practical divides are between epithelium-off and epithelium-on approaches, and between conventional and accelerated protocols, each trading treatment time against depth and predictability of effect. Corneal thickness remains the limiting safety parameter.

Where visual rehabilitation fits

Halting progression does not restore vision, and the two run in parallel rather than in sequence:

• Rigid and scleral contact lenses, still the mainstay of visual rehabilitation in irregular corneas.
• Intrastromal corneal ring segments, to regularise the cornea in selected topographic patterns.
• Keratoplasty — DALK where the endothelium is healthy — reserved for corneas that scarring or extreme irregularity have taken beyond lens correction.

That last step is a distinct surgical discipline; our cornea programme covers keratoplasty technique alongside ocular surface disease.

Cross-linking treats the disease. Lenses and rings treat the vision. Confusing the two is how expectations go wrong.

What this means in clinic

1. Image, do not just refract, when a young patient's astigmatism is changing.
2. Screen the fellow eye and offer screening to first-degree relatives.
3. Document progression properly before treating — and on consistent equipment.
4. Separate the two conversations: stopping the disease, and improving the vision.
5. Ask about eye rubbing every visit. It remains the modifiable factor.

In short

The modern management of keratoconus is a detection problem before it is a treatment problem. Find it early, document progression honestly, cross-link to stop it, and rehabilitate the vision separately — in that order.